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Abstract
Background: The literature on the implementation of knowledge products is extensive. However, this literature is
still difficult to interpret for policymakers and other stakeholders when faced with choosing implementation
strategies likely to bring about successful change in their health systems. This work has the particularity to examine
the scope of this literature, and to clarify the effectiveness of implementation strategies for different knowledge
products. Consequently, we aim to (1) determine the strengths and weaknesses of existing literature overviews; (2)
produce a detailed portrait of the literature on implementation strategies for various knowledge products; and (3)
assess the effectiveness of implementation strategies for each knowledge product identified and classify them.
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Methods: We will use a three-phase approach consisting of a critical analysis of existing literature overviews, a
systematic review of systematic reviews, and a series of systematic reviews and meta-analyses. We will follow the
Cochrane Methodology for each of the three phases. Our eligibility criteria are defined following a PICOS approach:
Population, individuals or stakeholders participating in healthcare delivery, specifically, healthcare providers,
caregivers, and end users; Intervention, any type of strategy aiming to implement a knowledge product including,
but not limited to, a decision support tool, a clinical practice guideline, a policy brief, or a decision-making tool, a
one-pager, or a health intervention; Comparison, any comparator will be considered; Outcomes, phases 1 and 2—
any outcome related to implementation strategies including, but not limited to, the measures of adherence/fidelity
to the use of knowledge products, their acceptability, adoption, appropriateness, feasibility, adaptability,
implementation costs, penetration/reach and sustainability; phase 3—any additional outcome related to patients
(psychosocial, health behavioral, and clinical outcomes) or healthcare professionals (behavioral and performance
outcomes); Setting, primary healthcare has to be covered. We will search MEDLINE (Ovid), EMBASE, Web of Science,
PsycINFO, CINAHL, and the Cochrane Library from their inception onwards. For each phase, two reviewers will
independently perform the selection of studies, data extraction, and assess their methodological quality. We will
analyze extracted data, and perform narrative syntheses, and meta-analyses when possible.
Discussion: Our results could inform not only the overviews’ methodology but also the development of an online
platform for the implementation strategies of knowledge products. This platform could be useful for stakeholders in
implementation science.
Systematic review registration: Protocol registered on Open Science Framework, https://osf.io/eb8w2/.
Keywords: Implementation strategies, Primary healthcare, Overviews, Systematic reviews, Meta-analysis
Background
Description of the condition
Having an evidence-based knowledge product does not
mean that it will be systematically implemented with
success and be beneficial for patients. Balas et al. [1] esti-
mated that it takes up to 17 years to translate 14% of
original research into practices for the benefit of pa-
tients. Given this gap between the production of health
evidence and its application in routine practice, increas-
ing attention has been devoted to knowledge translation
(KT), and more specifically, to KT [2, 3] and implemen-
tation strategies [3–5]. Knowledge products considered
in implementation strategies include clinical practice
guidelines, shared decision-making tools, decision
support tools, policy briefs, a one-pager (simple, icono-
graphic, infographic), and a health intervention (techno-
logical, pharmacological, behavioral, or management).
As a result, there has been a substantial increase in stud-
ies examining their effectiveness.
Description of the implementation
Implementation can be defined as an actively planned
and deliberatively initiated effort with the intention to
translate a given knowledge product into practices in a
particular setting and context [6, 7]. Implementation re-
quires characterizing the knowledge product to be im-
plemented as well as the context and setting of
implementation [7]. It is also important to (1) determine
an adapted process framework or theory; (2) clarify the
different stages of the implementation process; (3)
identify stakeholders to be involved; (4) recognize
facilitators and barriers to implementation using an ap-
propriate framework; (5) identify the corresponding im-
plementation strategies; and (6) target the relevant
outcomes and tools to evaluate them [7]. Implementa-
tion strategies have been explored extensively in the lit-
erature. They can be defined as techniques or methods
aiming to improve or optimize the uptake and routine
application of complex interventions in clinical care [5].
To be better characterized, implementation strategies
have to be named, defined, and specified [5]. The
Cochrane Effective Practice and Organization of Care
(EPOC) grouped existing implementation strategies in
categories targeting respectively healthcare organiza-
tions, healthcare professionals, specific types of practice,
condition, or setting [3].
How the knowledge product implementation might work
The implementation of a given knowledge product
should be guided by one or more frameworks/models/
theories depending on its complexity. As suggested by
Nilsen [8], an implementation process, identification of
its determinants, and evaluation of its outcomes may be
supported by a framework/model/theory. Indeed, frame-
works/models/theories permit stakeholders to better ex-
plain and clarify different steps of the implementation
process, i.e., a description of the main steps to translate
a given knowledge product into practices followed by
the evaluation of outcomes and the sustainability of its
use (e.g., the knowledge to action framework [9]).
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Frameworks/models/theories can also be used to better
address the various levels of factors that potentially in-
fluence implementation outcomes (e.g., the Consolidated
Framework for Implementation Research, CFIR [7]). Fi-
nally, there are frameworks/models/theories that have
been developed to optimally address the various levels of
outcomes that can both explain how different steps of
the implementation process took place as well as indi-
cate the timeline for their evaluation [10, 11].
Why it is important to do a series of systematic reviews
According to our preliminary literature search, we found
that the literature on the implementation of knowledge
products is large. In an effort to further synthesize, sev-
eral overviews of these systematic reviews [4, 12–21]
have been published in the last 20 years. Overviews at-
tempt to systematically retrieve and summarize the re-
sults of multiple systematic reviews on the effectiveness
of interventions or treatments for a given condition or
public health problem [22]. Their purpose is to contrast
the findings of several systematic reviews on the same
subject, thus offering decision-makers a broader under-
standing of the evidence. While, in theory, this type of
study has the potential to overview the evidence, its exe-
cution is fraught with several challenges. There are
guidelines for conducting this type of research [23–26];
however, several experts who have examined the meth-
odology regarding overviews of systematic reviews over
the past decade agreed that existing directives and rec-
ommendations are not sufficiently robust and there is
great room for improvement [27–29].
This literature remains difficult to interpret for policy-
makers and other stakeholders when faced with having
to select implementation strategies likely to bring about
successful change in their health systems. Indeed, it re-
mains a challenge to determine what strategy is effective
for the implementation of a given knowledge product.
Examining the scope of this literature and further clari-
fying the effectiveness of implementation strategies for
different knowledge products could serve to identify ori-
ginal and relevant research questions for future system-
atic reviews. In turn, these latter may allow us to
quantitatively assess the effectiveness of implementation
strategies for specific knowledge products. The general
aim of this project is to identify, for each category of
knowledge product, the most effective implementation
strategies for their uptake into healthcare professionals’
clinical practice.
We aim to address the following specific objectives in
three distinct phases:
1. Phase 1—to perform a critical analysis of existing
literature overviews to determine their strengths
and weaknesses. This analysis will not only help us
better define our research question for subsequent
phases but will also highlight many of the
methodological challenges we may encounter.
2. Phase 2—to conduct a systematic review of
systematic reviews while taking into account the
weaknesses of previously published overviews, and
provide a detailed portrait of the literature on
various implementation strategies for knowledge.
3. Phase 3—to perform a series of meta-analyses that
evaluate the effectiveness of implementation strat-
egies for the different types of knowledge products,
using individual randomized controlled trials
(RCTs) from systematic reviews included in phase
2. These analyses will provide answers to specific
research questions with the most robust experimen-
tal study designs, and more detailed ones, in which
contextual elements, often absent in overviews, are
going to be taken into consideration.
Methods
This study protocol has been registered within the Open
Science Framework platform (Registration ID: https://
osf.io/eb8w2/). We are reporting it in accordance with
the reporting guidance provided in the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses
Protocols (PRISMA-P) statement (See PRISMA-P check-
list in Additional file 2) [30]. We will conduct this pro-
ject following the recommendations in the Cochrane
Handbook for systematic reviews [31].
We will use a three-phase approach (see Fig. 1 for de-
tails) including a critical analysis of existing literature
overviews, a systematic review of systematic reviews, and
a series of systematic reviews and meta-analyses.
Eligibility criteria
In the first two phases of the project, according to a
PICOS (Population, Intervention, Comparison, Out-
comes, Study design) with knowledge products, studies
that meet the following criteria will be considered for
inclusion:
Population
The population of interest is individuals or stakeholders
participating in healthcare delivery, specifically, health-
care providers, caregivers, and end users (i.e., patients or
clients with any conditions).
Intervention
We will consider any type of strategy aiming to imple-
ment a knowledge product. The EPOC taxonomy will be
used to classify implementation strategies identified (e.g.,
audit and feedback, educational meetings, interprofes-
sional education) [3].
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Knowledge product
As suggested by Pinnock et al. [32], a clear distinction
has been made between the implementation strategies
and the knowledge products implemented. A knowledge
product could be, but not limited to, a decision support
tool, a clinical practice guideline, a policy brief, or a
decision-making tool, a one-pager (simple, iconographic,
infographic), or a health intervention (technological,
pharmacological, behavioral, or management). Only im-
plementation studies in which both are reported will be
considered in our project.
Comparison
Any comparator will be considered. This includes stud-
ies in which two or more implementation strategies for
knowledge products are compared (head to head); and
studies in which there is no comparator.
Outcome(s)
In phases 1 and 2, we will mainly consider outcomes re-
lated to implementation strategies including, but not
limited to, the measures of adherence/fidelity to the use
of knowledge products, their acceptability, adoption,
appropriateness, feasibility, adaptability, implementation
costs, penetration/reach, and sustainability [11]. As for
phase 3, we will additionally consider the outcomes
related to patients (psychosocial, health behavioral, and
clinical outcomes) or healthcare professionals
(psychosocial, health behavioral, and performance out-
comes) that the knowledge products aim to improve.
Study design
This eligibility criterion will be specific to each phase of
the project:
 Phase 1. We will consider any review of reviews on
implementation strategies for knowledge products
(i.e., a knowledge synthesis in which included
studies are any literature reviews).
 Phase 2. We will consider only systematic reviews
(i.e., any study in which authors performed a
narrative and/or quantitative synthesis of
experimental studies on implementation strategies
for knowledge products using a comprehensive and
reproducible approach).
 Phase 3. Only RCTs will be considered.
Setting
Any health domain addressed in primary healthcare will
be considered. A review will be included if primary
healthcare is covered.
Information sources and search strategy
We will perform comprehensive searches within five
electronic databases: MEDLINE (Ovid), EMBASE, Web
of Science, PsycINFO, CINAHL, and the Cochrane
Phase 1: Critical analysis of 
existing overviews 
Aim: To critically describe existing 
overviews
Studies considered: Overviews
Analysis: Critical analysis of 
methods and results
Expected results: We hope to 
identify methodological limitations 
that could be overcome in our own 
overview in order to provide more 
conclusive results.
Phase 2: A systematic review of 
systematic reviews 
Aim: To describe existing 
systematic reviews
Studies considered: Systematic 
reviews
Analysis: Descriptive analysis
Expected results: From systematic 
reviews of good quality, we hope to 
identify frequently reported 
populations studied, 
implementation strategies, 
knowledge products implemented, 
and outcomes analyzed. Then we 
will classify them.
Phase 3: Specific systematic 
reviews and/or meta-analyses
Aim: To assess the effectiveness of 
implementation strategies, for each 
category of knowledge products
Studies considered: RCTs
Analysis: Narrative synthesis 
and/or meta-analysis 
Expected results: We hope to be 
able to identify the best 
implementation strategies for each 
category of knowledge products.
What are the implementation strategies aiming to improve the use of knowledge products and what is their effectiveness?
Fig. 1 Three-phase approach used for the present review
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Library from their inception onwards. The search strat-
egy will be designed by an information specialist using
“knowledge transfer” and “implementation strategies”
headings (See draft search strategy for MEDLINE/Ovid
in Additional file 1). For efficiency considerations, we
will not build a new search strategy to identify RCTs,
rather, we plan in identifying them from the systematic
reviews that we will select in our overview. However, to
avoid missing any recently published RCTs in the field,
we will update our search strategy by looking for pri-
mary studies published after the most recent included
reviews. Searches will be conducted within the same
electronic databases as in earlier phase. Study designs
other than RCTs, for example systematic reviews, quasi-
experimental studies and observational studies, will be
excluded.
There will be neither language nor literature search
date restrictions. The references listed in all eligible
studies will also be manually searched in order to iden-
tify additional relevant ones.
Data management
We will merge the citations identified from five elec-
tronic databases mentioned above in the EndNote soft-
ware. Then, we will identify and remove the duplicates.
The unique citations will be considered for the selection
process.
Selection of studies
Two assessors will independently contribute to all steps
of the selection process. References identified from rele-
vant electronic databases will be merged, and duplicates
removed to obtain a database including unique citations
for the study selection process. Assessors will discuss the
inclusion criteria to ensure mutual understanding, and
pilot test on five percent of unique citations identified to
confirm that the evaluation process is reliable. The pilot
section will be considered conclusive if the kappa statis-
tic referring to the agreement between assessors is
greater than 0.7 [33].
Pairs of assessors will then independently screen for ti-
tles and abstracts based on inclusion criteria specific to
each phase outlined above. In case of doubt, the citations
will be included and considered for full-text reading. As-
sessors will then independently screen the full texts of
references retained at the first step. Any disagreement
will be resolved by consensus or by involving a third
assessor.
Assessors will include overviews for phase 1 and sys-
tematic reviews for phase 2, based on the eligibility cri-
teria mentioned above. For phase 3, the following
procedure will be adopted for the identification of rele-
vant RCTs from each review considered: first, we will go
through the list including primary studies to identify
RCTs that are clearly reported as such by the review’s
authors. In the case, RCTs are not, we will select the
complete list of primary articles included. Removal of
duplicates and screening based only on the study design
will be done by two independent assessors.
Data extraction
For each phase, a pilot data extraction will be done on
5% of selected articles. The data extraction will be pur-
sued only when the pilot is conclusive. This process will
be independently performed by two assessors. Discrep-
ancies between them will be resolved by a third author.
Phase 1
The following data will be extracted: the first author’s
name; the year of publication; the focus of the overview,
based on the scope of PICO elements; the number and
name of databases consulted; the period of the literature
search; the strategies used to update the literature; the
type and number of reviews that are included; the type
of reviews (Cochrane, non-Cochrane, both); the strat-
egies to deal with the overlap between reviews; the strat-
egies to deal with conflicting results of reviews; the
quality assessment of reviews; the type of synthesis per-
formed (narrative, meta-analysis or both); the assessment
of the quality of evidence, and the limitations reported
by overview authors.
Phase 2
We will extract data concerning the following elements:
 Review details. First author’s name, year of
publication, type, objectives, registration
information.
 Literature search details. Number and names of
electronic databases, search for gray literature,
search period, restrictions, design and number of
primary studies.
 Characteristics of participants. Name, profile, total
number, age (mean, median, and/or range), gender
(percentage of men or women).
 Characteristics of implementation strategies.
Components described according to the EPOC
taxonomy, knowledge products implemented (e.g.,
clinical guidelines, health intervention).
 Characteristics of outcomes. Name, type of
measurement tools used (self-administered,
objective, both). We will use Proctor et al. taxonomy
to guide the classification of outcomes [11].
 Assessment of study quality. Name of the tool used,
result.
 Type of synthesis. Narrative, meta-analysis, or both.
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 Assessment of publication bias. Method used (funnel
plots, statistical tests, both), and treatment of it if
present.
 Assessment of the quality of evidence. Name of the
tool used, level of evidence.
 Conclusion of reviews. Information reported by
authors when they conclude (e.g., main results and
limitations).
Phase 3
For each RCT considered in this phase, we will extract
data concerning the following elements:
 Characteristics of the study. First author’s name, year
of publication, country, language, healthcare
domain, setting, study design, sampling, and
recruitment method.
 Characteristics of participants. Size of eligible
population for both healthcare providers and end
users, total sample size, sample sizes in
implementation strategy, and control groups, unit of
allocation, mean age or range, sex, race/ethnicity
(percentage of Caucasians), socioeconomic level of
the sampled population, and profile.
 Characteristics of implementation strategies
(description of the intervention). Components
(according to the EPOC taxonomy), underlying
framework, content, number of participating
centers, mode of delivery (e.g., in person and
online), actual duration (e.g., number of hours),
actual frequency (e.g., number of sessions), methods
used (e.g., interactive or didactic techniques, web
applications), course materials used (e.g., web
capsules, textbooks), adherence/fidelity, and content
of the intervention offered to control group.
 Characteristics of knowledge products implemented.
Name, format and content.
 Characteristics of outcomes and analysis methods
used. Names of interest outcomes, measurement
tools, range of scale and analysis methods used, unit
of analysis, intention to treat analysis or not,
retention rates, and effect measures of
implementation strategies.
 Effects of implementation strategies. Any information
useful to estimate the effect size and its 95%
confidence interval will be extracted. For continuous
outcomes, we will consider the standardized mean
difference as effect size requiring the sample size,
mean score, and standard deviation in each group
studied. For dichotomous outcomes, we will
consider the odds ratio as effect size requiring the
sample size and number of events in each group
studied. We will also collect the value of effect size
(crude and adjusted) and its confidence interval
estimated in the studies. Information about
confounding factors will as well be extracted.
When necessary, corresponding or first authors will be
contacted to obtain information about missing data in
their studies.
Quality assessment of studies
The quality of overviews retrieved in phase 1 will not be
assessed since there is no methodological tool designed
for this purpose. Moreover, the objective of this phase is
not to draw any conclusions on the effectiveness of im-
plementation strategies from these overviews.
For phase 2, we will assess the methodological quality
of selected systematic reviews using the AMSTAR 2 tool
[34]. Those meeting the criteria of good or medium
quality will be retained for the rest of the process, i.e.,
will be considered for the next steps of the review of re-
views and for the identification of RCTs in phase 3.
As for phase 3, RCTs extracted from systematic re-
views will be assessed with the Cochrane Risk of Bias
(RoB) 2.0 tool [35].
Both the quality assessment of systematic reviews as
the assessing risk of bias for RCTs will be performed in-
dependently by two authors. In a pilot assessment of two
or four studies included, they will agree on a common
understanding of the definitions, criteria, and guidelines
provided in the tool to achieve a more objective assess-
ment. The assessment of all studies included will do
once the pilot test is conclusive. When needed, a third
reviewer will be invited to help reach consensus.
Data synthesis
Phase 1
We will perform a descriptive analysis using counts
(number and percentage) to summarize data collected
followed by carrying out a critical analysis on the latter
considering the following methodological elements: lit-
erature search, methodological limitations reported in
overviews, overlap between reviews included in over-
views, types of data synthesis, quality of reviews included
in overviews, and level of evidence.
Phase 2
We will produce a descriptive Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
flowchart of the selection process for all included re-
views [36]. We will then describe the characteristics of
the latter, populations, implementation strategies, and
outcomes assessed. We will also analyze the data on
publication bias and quality of evidence assessment. Fi-
nally, evaluation data of included reviews from the
AMSTAR 2 tool [34] will be presented using a graph
and table.
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Phase 3
First, we will classify RCTs according to the type of
knowledge product being implemented. These may
include but not limited to clinical guidelines, decision
support tools, research summaries, one-pagers (simple,
iconographic, infographic), or other health interventions
(technological, pharmacological, behavioral, or
management).
Second, we will present a descriptive flowchart of the
RCTs included in each meta-analysis, according to the
PRISMA guidelines [36]. We will describe by frequencies
(number and percentage) the characteristics of studies,
populations, implementation strategies, and outcomes.
Risk of bias levels will also be described for all included
RCTs.
Finally, for each outcome and knowledge product, we
will determine if there are sufficient data to perform a
meta-analysis. If not, we will conduct a narrative synthesis
on the effects of implementation strategies, and include in
tables and figures to aid in data presentation. If so, we will
do a meta-analysis. For each outcome and knowledge
product, the random effect model will be used to estimate
the pooled effect size of an implementation strategy and
its 95% confidence interval, as we anticipate heterogeneity
among the RCTs concerning the types of implementation
intervention and population [31, 37]. For dichotomous
data, the effect size will be expressed as a risk ratio or odds
ratio; for continuous data, it will be provided as a stan-
dardized mean difference if different measures are used
for the same outcome. For cluster RCTs, the analysis will
be adjusted for clustering to avoid unit-of-analysis errors
[31]. The influence of clinical and methodological hetero-
geneity on the observed effects will be discussed. Sub-
group analyses will be carried out if necessary according
to characteristics of the studies, the populations and the
implementation interventions mentioned above. Statistical
heterogeneity will be assessed using the Higgins’ I square
statistic [38, 39]. A funnel plot will be generated to assess
publication bias if 10 or more studies are included in the
meta-analysis [40]. Statistical tests for funnel plot asym-
metry (e.g., Egger’s regression, Begg’s test, and Harbord’s
test) will be performed where appropriate [31, 40].
Sensitivity analyses will be carried out excluding the
RCTs with high risk of bias from pooled effect size esti-
mates. For each outcome and knowledge product, we
will also explore the influence of each RCT by removing
its individual effect size from the pooled estimation.
These different analyses will allow us to evaluate the ro-
bustness of our results.
Assessment of the quality of evidence
The quality of evidence for each outcome and
knowledge product will be assessed with the Grading of
Recommendations, Assessment, Development and
Evaluation (GRADE) to reduce the misinterpretation of
our review’s results [41]. The GRADE tool is based on
five criteria for each individual study, namely risk of bias,
indirectness of evidence, data heterogeneity, imprecision
of effect size estimates, and risk of publication bias [41].
Overall assessment will be rated very low, low, moderate,
and high for each outcome [41].
Discussion
Our project aims to improve the usefulness of evidence
on implementation strategies for knowledge products in
primary healthcare. Our expected findings will have both
methodological and practice implications. First, findings
from the present project, mainly the ones related to the
critical analysis on methodology, will contribute to
methodological aspects for designing and conducting
literature overviews. To this end, we will identify meth-
odological limitations in overviews, and formulate corre-
sponding recommendations with our collaborative team
of methodologists. These recommendations will be ap-
plied to our own overview in order to determine their
applicability. Second, our findings will also serve to pro-
vide a list of implementation strategies for various know-
ledge products. This list will include established effective
implementation strategies, those potentially effective,
and the non-effective ones for each knowledge product
identified. These findings will inform the development of
an online platform on implementation strategies for
knowledge products in primary healthcare.
Apart from the methodological challenges already
taken into account in our methods section, we anticipate
other limitations in the realization of our project. First,
there may be discrepancies between what we have
planned in this protocol and what we will finally do. So,
we plan for justifying them and documenting important
protocol amendments. Second, doing a series of system-
atic reviews can take a long time, so it could be challen-
ging to keep update the literature search of interest. To
save time, we plan to create parallel review teams that
will simultaneously work at the steps of study selection,
data extraction, and/or study quality assessment for the
critical analysis of existing overviews and the systematic
reviews of systematic reviews. For each systematic review
of RCTs on specific research questions, we plan to sys-
tematically update our literature search to avoid missing
any recently published RCTs.
We will use passive and active strategies to dissemin-
ate our findings.
Passive strategies
Findings from this project will be published in leading
journals in the field intended for knowledge users and
stakeholders in implementation science. We plan to
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produce a series of manuscripts for publication in peer-
reviewed journals organized in the following:
 A manuscript as a preamble in which we will report
results from our critical analysis of existing
overviews
 A paper describing results from our overview and
our original methodology
 At least four manuscripts corresponding to each
specific meta-analysis or narrative synthesis we will
perform. In these papers, we will identify effective
implementation strategies for each type of know-
ledge product
The findings will also be presented at local, national,
and international conferences (number equal to four or
six). Specialized conferences whose themes related to
knowledge translation in health, implementation science,
or primary healthcare will be privileged (e.g., the Annual
Scientific Meeting of Knowledge Translation Canada,
the Annual Conference on the Science of Dissemination
and Implementation in Health, or the Annual Meeting
of North American Primary Care Research Group). In
these cases, we will solicit our expert partners on know-
ledge translation to participate as credible messengers.
Finally, we will design a database on our website (http://
unitesoutiensrapqc.ca/) on the effectiveness of imple-
mentation strategies stratified according to the types of
outcomes and knowledge products. This database will be
useful for anyone who wants to design an implementa-
tion study on a knowledge product.
Active strategies
Findings from this project are of critical relevance to
each of the following knowledge platforms or teams: the
Knowledge Translation Components of Strategy for
Patient-Oriented Research (SPOR) - Support for People
and Patient-Oriented and Trials (SUPPORT) Units, the
Réseau provincial de recherche en adaptation-
réadaptation (REPAR), and the Centre de recherche
interdisciplinaire en réadaptation (CRIR). One of the
mandates from these organizations is to guide the appli-
cation of evidence-based knowledge in primary care clin-
ical practices, as well as in rehabilitation. Since our
findings will be the product of a systematic approach, we
will integrate them into the range of services we offer,
including training workshops (e.g., for conferences or as
interactive online training with a follow-up) targeting
specific audiences such as health administrators/deci-
sion-makers/health professionals and patients. We will
also develop a platform on implementation strategies for
knowledge products in primary healthcare. A video cap-
sule in plain language will be created to support the use
of this platform and to train the potential users
including healthcare professionals, health system
decision-makers, patients, and researchers involving in
implementation science. We will use various communi-
cation channels to publicize our platform: social media
(e.g., Facebook, Twitter), our bimonthly newsletter
(more than 500 subscribers), and clients’ emails through
the database, particularly those who accepted to be con-
tacted for our advertisements.
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